Paradoxical Tuberculosis Reactions in Patients Without HIV Infection
Condition:   Tuberculosis Intervention:   Sponsor:   National Institute of Allergy and Infectious Diseases (NIAID) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 9, 2019 Category: Research Source Type: clinical trials

Performance Evaluation of the VIDAS TB-IGRA Assay.
Conditions:   Active Tuberculosis;   Latent Tuberculosis Infection;   Non-Tuberculous Mycobacterial Pneumonia Intervention:   Diagnostic Test: Blood draw and IGRA test Sponsor:   BioMérieux Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 7, 2019 Category: Research Source Type: clinical trials

BTZ-043 - Multiple Ascending Dose (MAD) to Evaluate Safety, Tolerability and Early Bactericidal Activity (EBA)
Conditions:   Pulmonary Tuberculoses;   Other Specified Pulmonary Tuberculosis Interventions:   Drug: BTZ-043;   Drug: Rifafour e-275®;   Drug: Probe Drug Cocktail;   Drug: Dolutegravir 50mg Tab Sponsors:   Michael Hoelscher;   European and Developing Countries Clinical Trials Partnership (EDCTP);   Radboud University;   German Federal Ministry of Education and Research Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 2, 2019 Category: Research Source Type: clinical trials

A One-stop Shop for the Same Day Diagnosis and Management of TB and HIV
Conditions:   Tuberculosis;   Hiv Interventions:   Diagnostic Test: CRP and Molbio Truenat MTB;   Diagnostic Test: CRP and Xpert ULTRA MTB/RIF;   Diagnostic Test: standard test Xpert;   Diagnostic Test: Culture as reference standard Sponsors:   Liverpool School of Tropical Medicine;   REACH Ethiopia;   Bingham University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 2, 2019 Category: Research Source Type: clinical trials

BTZ-043 - Multiple Ascending Dose (MAD) to Evaluate Safety, Tolerability and Early Bactericidal Activity (EBA)
Conditions:   Pulmonary Tuberculoses;   Other Specified Pulmonary Tuberculosis Interventions:   Drug: BTZ-043;   Drug: Rifafour e-275®;   Drug: Probe Drug Cocktail;   Drug: Dolutegravir 50mg Tab Sponsors:   Michael Hoelscher;   European and Developing Countries Clinical Trials Partnership (EDCTP);   Radboud University;   German Federal Ministry of Education and Research Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 2, 2019 Category: Research Source Type: clinical trials

A One-stop Shop for the Same Day Diagnosis and Management of TB and HIV
Conditions:   Tuberculosis;   Hiv Interventions:   Diagnostic Test: CRP and Molbio Truenat MTB;   Diagnostic Test: CRP and Xpert ULTRA MTB/RIF;   Diagnostic Test: standard test Xpert;   Diagnostic Test: Culture as reference standard Sponsors:   Liverpool School of Tropical Medicine;   REACH Ethiopia;   Bingham University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 2, 2019 Category: Research Source Type: clinical trials

BTZ-043 - Multiple Ascending Dose (MAD) to Evaluate Safety, Tolerability and Early Bactericidal Activity (EBA)
Conditions:   Pulmonary Tuberculoses;   Other Specified Pulmonary Tuberculosis Interventions:   Drug: BTZ-043;   Drug: Rifafour e-275®;   Drug: Probe Drug Cocktail;   Drug: Dolutegravir 50mg Tab Sponsors:   Michael Hoelscher;   European and Developing Countries Clinical Trials Partnership (EDCTP);   Radboud University;   German Federal Ministry of Education and Research Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 2, 2019 Category: Research Source Type: clinical trials

A One-stop Shop for the Same Day Diagnosis and Management of TB and HIV
Conditions:   Tuberculosis;   Hiv Interventions:   Diagnostic Test: CRP and Molbio Truenat MTB;   Diagnostic Test: CRP and Xpert ULTRA MTB/RIF;   Diagnostic Test: standard test Xpert;   Diagnostic Test: Culture as reference standard Sponsors:   Liverpool School of Tropical Medicine;   REACH Ethiopia;   Bingham University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 2, 2019 Category: Research Source Type: clinical trials

BTZ-043 - Multiple Ascending Dose (MAD) to Evaluate Safety, Tolerability and Early Bactericidal Activity (EBA)
Conditions:   Pulmonary Tuberculoses;   Other Specified Pulmonary Tuberculosis Interventions:   Drug: BTZ-043;   Drug: Rifafour e-275®;   Drug: Probe Drug Cocktail;   Drug: Dolutegravir 50mg Tab Sponsors:   Michael Hoelscher;   European and Developing Countries Clinical Trials Partnership (EDCTP);   Radboud University;   German Federal Ministry of Education and Research Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 2, 2019 Category: Research Source Type: clinical trials

A One-stop Shop for the Same Day Diagnosis and Management of TB and HIV
Conditions:   Tuberculosis;   Hiv Interventions:   Diagnostic Test: CRP and Molbio Truenat MTB;   Diagnostic Test: CRP and Xpert ULTRA MTB/RIF;   Diagnostic Test: standard test Xpert;   Diagnostic Test: Culture as reference standard Sponsors:   Liverpool School of Tropical Medicine;   REACH Ethiopia;   Bingham University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 2, 2019 Category: Research Source Type: clinical trials

BTZ-043 - Multiple Ascending Dose (MAD) to Evaluate Safety, Tolerability and Early Bactericidal Activity (EBA)
Conditions:   Pulmonary Tuberculoses;   Other Specified Pulmonary Tuberculosis Interventions:   Drug: BTZ-043;   Drug: Rifafour e-275®;   Drug: Probe Drug Cocktail;   Drug: Dolutegravir 50mg Tab Sponsors:   Michael Hoelscher;   European and Developing Countries Clinical Trials Partnership (EDCTP);   Radboud University;   German Federal Ministry of Education and Research Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 2, 2019 Category: Research Source Type: clinical trials

A One-stop Shop for the Same Day Diagnosis and Management of TB and HIV
Conditions:   Tuberculosis;   Hiv Interventions:   Diagnostic Test: CRP and Molbio Truenat MTB;   Diagnostic Test: CRP and Xpert ULTRA MTB/RIF;   Diagnostic Test: standard test Xpert;   Diagnostic Test: Culture as reference standard Sponsors:   Liverpool School of Tropical Medicine;   REACH Ethiopia;   Bingham University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 2, 2019 Category: Research Source Type: clinical trials

BTZ-043 - Multiple Ascending Dose (MAD) to Evaluate Safety, Tolerability and Early Bactericidal Activity (EBA)
Conditions:   Pulmonary Tuberculoses;   Other Specified Pulmonary Tuberculosis Interventions:   Drug: BTZ-043;   Drug: Rifafour e-275®;   Drug: Probe Drug Cocktail;   Drug: Dolutegravir 50mg Tab Sponsors:   Michael Hoelscher;   European and Developing Countries Clinical Trials Partnership (EDCTP);   Radboud University;   German Federal Ministry of Education and Research Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 2, 2019 Category: Research Source Type: clinical trials

A One-stop Shop for the Same Day Diagnosis and Management of TB and HIV
Conditions:   Tuberculosis;   Hiv Interventions:   Diagnostic Test: CRP and Molbio Truenat MTB;   Diagnostic Test: CRP and Xpert ULTRA MTB/RIF;   Diagnostic Test: standard test Xpert;   Diagnostic Test: Culture as reference standard Sponsors:   Liverpool School of Tropical Medicine;   REACH Ethiopia;   Bingham University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 2, 2019 Category: Research Source Type: clinical trials

BTZ-043 - Multiple Ascending Dose (MAD) to Evaluate Safety, Tolerability and Early Bactericidal Activity (EBA)
Conditions:   Pulmonary Tuberculoses;   Other Specified Pulmonary Tuberculosis Interventions:   Drug: BTZ-043;   Drug: Rifafour e-275®;   Drug: Probe Drug Cocktail;   Drug: Dolutegravir 50mg Tab Sponsors:   Michael Hoelscher;   European and Developing Countries Clinical Trials Partnership (EDCTP);   Radboud University;   German Federal Ministry of Education and Research Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 2, 2019 Category: Research Source Type: clinical trials